{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"US_9096653_B2","frontPageModel":{"patentViewModel":{"ref":{"entityRefType":"PATENT","entityRefId":"187-008-375-545-874"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":8676,"type":"PATENT","title":"New York University Patent Portforlio ","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":5145,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2015-11-12T00:15:20Z","updated":"2015-11-23T01:36:42Z","lastEventDate":"2015-11-23T01:36:42Z"},{"id":8877,"type":"PATENT","title":"New York Univ Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":15466,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8211,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners seperately = \"New York Univ\", \"New York University NOT \"state\" NOT \"city\" \", \"Univ New York\", \"NYU\".
Search Applicants and Owners seperately = \"New York Univ\", \"New York University NOT \"state\" NOT \"city\" \", \"Univ New York\", \"NYU\".
a peptide comprising at least one repeat circumsporozoite protein selected from the group consisting of (NPNA)x, (PNAN)x, and (ANPN)x, wherein x is four to six;\n
covalently linked to at least one other immunogenic protein selected from the group consisting of bovine serum albumin, ovalbumin, tetanus toxoid, diphtheria toxoid, cholera toxin, Clostridium difficile toxin A, Clostridium difficile toxin B, and Pseudomonas aeruginosa recombinant exoprotein A, wherein the conjugate elicits an immune response to a Plasmodium falciparum circumsporozoite protein in a subject."],"number":1,"annotation":false,"title":false,"claim":true},{"lines":["The immunogenic conjugate of claim 1, wherein the covalent linkage comprises a non-peptide linkage."],"number":2,"annotation":false,"title":false,"claim":true},{"lines":["The immunogenic conjugate of claim 2, wherein the non-peptide linkage comprises at least one linkage selected from the group consisting of an amide linkage, a hydrazone linkage, a thioether linkage, and a combination of two or more thereof."],"number":3,"annotation":false,"title":false,"claim":true},{"lines":["The immunogenic conjugate of claim 1, wherein the at least one repeat comprises (NPNA)4 or (NPNA)5."],"number":4,"annotation":false,"title":false,"claim":true},{"lines":["The immunogenic conjugate of claim 1, wherein the at least one repeat comprises (PNAN)4 or (PNAN)5."],"number":5,"annotation":false,"title":false,"claim":true},{"lines":["The immunogenic conjugate of claim 1, wherein the at least one repeat comprises (ANPN)4 or (ANPN)5."],"number":6,"annotation":false,"title":false,"claim":true},{"lines":["A method of eliciting an immune response to a circumsporozoite protein of Plasmodium falciparum in a host, comprising administering the immunogenic conjugate of claim 1 to the host."],"number":7,"annotation":false,"title":false,"claim":true},{"lines":["The method of claim 7, wherein the host is a human."],"number":8,"annotation":false,"title":false,"claim":true},{"lines":["A pharmaceutical composition for eliciting an immune response to circumsporozoite protein of Plasmodium falciparum in a host, the composition comprising the immunogenic conjugate of claim 1 and a pharmaceutically acceptable carrier."],"number":9,"annotation":false,"title":false,"claim":true},{"lines":["The pharmaceutical composition of claim 9, further comprising an adjuvant."],"number":10,"annotation":false,"title":false,"claim":true},{"lines":["The pharmaceutical composition of claim 10, wherein the adjuvant is aluminum hydroxide."],"number":11,"annotation":false,"title":false,"claim":true},{"lines":["A method of eliciting an immune response to a circumsporozoite protein of Plasmodium falciparum in a host, comprising administering the pharmaceutical composition of claim 9 to the host."],"number":12,"annotation":false,"title":false,"claim":true}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}